Stocks Health care CYRX
NASDAQ · Health careCryoport, Inc. (CYRX)
Cryoport, Inc. brought in $192.4M of revenue over the twelve months to September 30, 2026, up 11.8% from a year earlier. It posted a net loss of $41.3M. In fiscal 2025 capital spending exceeded operating cash flow by $25M. At September 30, 2026 it held $279.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Cryoport, Inc.
- Net worth
- Cryoport, Inc. has a market value (market cap) of $1B at the latest share price, and shareholders' equity of $483.5M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $176.2M (+12.4% year on year), with net income of $78.3M. Over the 12 months to September 30, 2026: revenue $192.4M, net loss $41.3M.
- Cash flow
- In fiscal 2025 operations used $8.6M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Cryoport, Inc.'s next report is expected around March 2, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Cryoport, Inc. does
Cryoport, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CYRX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $176.2M | $78.3M | $1.40 | -$25M |
| 2024 | $156.8M | -$114.8M | -$2.49 | -$33.6M |
| 2023 | $168.7M | -$99.6M | -$2.21 | -$39.5M |
| 2022 | $237.3M | -$37.3M | -$0.93 | -$24M |
| 2020 | $222.6M | -$275.5M | -$6.18 | -$15.8M |
| 2020 | $78.7M | -$32.7M | -$1.94 | -$23.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where CYRX ranks in Health care
Latest SEC filings
What Cryoport, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 14% to $50.2M versus the same quarter last year; diluted EPS -$0.25 versus -$0.18.
- November 5, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 7.7% to $49M versus the same quarter last year; diluted EPS -$0.20 versus $2.13.
- August 6, 2026
- July 29, 2026Passive stake changed SCHEDULE 13G/A
- June 22, 2026
- June 22, 2026Deregistration 15-12G
- June 9, 2026
Insider trades
What the people running Cryoport, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 11, 2026 | Shelton JerrellPresident, CEO, Director | Soldpre-planned (10b5-1) | 28,800 | $429.4K |
| June 11, 2026 | Zecchini Edward JChief Digital and Tech Officer | Exercised options | 33,600 | $161.3K |
| June 11, 2026 | Zecchini Edward JChief Digital and Tech Officer | Sold | 33,600 | $486.2K |
| June 10, 2026 | Zecchini Edward JChief Digital and Tech Officer | Exercised options | 1,400 | $6.7K |
| June 10, 2026 | Zecchini Edward JChief Digital and Tech Officer | Sold | 1,400 | $21.3K |
| June 8, 2026 | Mandalam RamkumarDirector | Sold | 23,214 | $358.5K |
| June 5, 2026 | Baddour LindaDirector | Received as pay | 10,350 | - |
| June 5, 2026 | Mandalam RamkumarDirector | Received as pay | 10,350 | - |
Who owns CYRX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Cadian Capital Management, LP13G, passive with 2 related filers | 5.8% | August 14, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 185 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 4,218,434 | +237,536 |
| Cadian Capital Management, LP | 2,920,681 | -1,855,662 |
| First Eagle Investment Management, LLC | 2,542,848 | +1,797,999 |
| Assenagon Asset Management S.A. | 2,304,622 | +808,939 |
| Morgan Stanley | 2,276,741 | -2,299,989 |
| Vanguard Capital Management LLC | 2,151,943 | +33,087 |
| Millennium Management LLC | 1,724,726 | -1,245,738 |
| Fred Alger Management, LLC | 1,545,293 | -154,086 |
| Geode Capital Management, LLC | 1,312,370 | +64,235 |
| Mak Capital One LLC | 1,277,359 | -145,906 |
| State Street Corp | 1,046,875 | +62,997 |
| Dimensional Fund Advisors LP | 1,000,095 | +76,388 |
| Nuveen, LLC | 922,935 | +822,319 |
| UBS Group AG | 868,266 | -64,516 |
| Silvercrest Asset Management Group LLC | 858,684 | -42,326 |
| Meros Investment Management, LP | 743,312 | +134,239 |
| Needham Investment Management LLC | 717,000 | +357,000 |
| Brown Capital Management LLC | 670,057 | -110,507 |
| Deutsche Bank AG\ | 654,889 | -345,787 |
| Intrinsic Edge Capital Management LLC | 630,000 | 0 |
Insiders
8 insiders reported holding 1,790,409 shares in total, about $35.6M at the last price.
| Holder | Shares |
|---|---|
| Shelton JerrellPresident, CEO, Director | 1,201,814 |
| Stefanovich RobertChief Financial Officer | 109,850 |
| Zecchini Edward JChief Digital and Tech Officer | 109,719 |
| Sawicki Mark WChief Scientific Officer | 102,356 |
| Hancock Daniel MDirector | 69,052 |
| Baddour LindaDirector | 68,099 |
| Mandalam RamkumarDirector | 67,894 |
| Hariri Robert JDirector | 61,625 |
Questions about CYRX
What does Cryoport, Inc. do?
Cryoport, Inc. is a company in the Health care sector, listed on NASDAQ as CYRX. Its shares trade on NASDAQ under the ticker CYRX.
What is Cryoport, Inc.'s net worth?
Cryoport, Inc. has a market value (market cap) of $1B at the latest share price, and shareholders' equity of $483.5M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Cryoport, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $41.3M on revenue of $192.4M.
How much revenue does Cryoport, Inc. make?
Over the twelve months to September 30, 2026 Cryoport, Inc. reported revenue of $192.4M. That is 11.8% more than a year earlier.
When did Cryoport, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the planned insider sale from November 9, 2026.
When is Cryoport, Inc.'s next earnings report?
Cryoport, Inc.'s next report is expected around March 2, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare CYRX with
Follow CYRX
Get an email when Cryoport, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Cryoport, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.